NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
You might also be interested in reading Bitcoin derivatives flash red as $1.79B long liquidation cluster forms below key resistance.
